Bär & Karrer Ltd.

Claudia Götz Staehelin's practice focuses on complex investigation and litigation matters at the intersection of civil, criminal and regulatory proceedings. Claudia leads large-scale internal investigations, supports her clients in crisis management and advises them on all aspects of their compliance framework. She represents and advises her clients in domestic and cross-border litigations, in international judicial and administrative assistance matters and in internal and regulatory investigations led by Swiss and foreign authorities. One of her industry focuses is the Healthcare & Life Sciences industry, where she advises clients on pharma regulatory and all compliance matters.

Based on her experience as former Head of Litigation at Novartis, Claudia regularly supports companies with multi-jurisdictional projects requiring innovative thinking. She has extensive international experience in litigation and investigation risk assessment, and in assisting clients with strategic decision-making. Her many years in-house and with corporate investigations have given her a deep understanding of the challenges and opportunities of ESG issues for companies.

Partner at a Swiss commercial law firm (2018-2023) Head Litigation of Novartis (2011-2018) Partner at a Zurich law firm (2007-2011) Associate at a Swiss commercial law firm (2002-2007) Admitted to the Basel-Stadt bar (2001)

German, English

Ethics and Compliance Switzerland (ECS) (Board Member) Women in White Collar Defense Association (Swiss Chapter) Association of Certified Fraud Examiners (ACFE) The Sedona Conference International Association of Privacy Professionals (IAPP) Swiss Arbitration Association (ASA)

LL.M., New York University, School of Law, Vanderbilt Scholar, specialization in US litigation (2005) University of Basel: Dr. iur. (2000) University of Basel: lic. iur. (1998)